Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

Details for Australian Patent Application No. 2009284092 (hide)

Owner Probiodrug AG

Inventors Cynis, Holger; Demuth, Hans-Ulrich; Gans, Kathrin; Kampfer, Sonja; Rahfeld, Jens-Ulrich; Schilling, Stephan

Agent Watermark

Pub. Number AU-A-2009284092

PCT Pub. Number WO2010/020669

Priority 61/090,264 20.08.08 US

Filing date 20 August 2009

Wipo publication date 25 February 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/020669 Priority application(s): WO2010/020669

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009284098-Pyrrolopyrimidine compounds as CDK inhibitors

2009284086-New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents